Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl‐Induced Systemic Sclerosis

M. Vozenin,F. Batteux,P. Roger,A. le Quellec,P. Guilpain,A. Maria,N. Pirot,C. Bony,B. Petit,C. Jorgensen,K. Toupet,D. Noël
DOI: https://doi.org/10.1002/art.39477
2016-04-01
Arthritis & Rheumatology
Abstract:Systemic sclerosis (SSc) is a rare intractable disease with unmet medical need and fibrosis‐related mortality. Absence of efficient treatments has prompted the development of novel therapeutic strategies, among which mesenchymal stem cells/stromal cells (MSCs) or progenitor stromal cells appear to be one of the most attractive options. The purpose of this study was to use the murine model of hypochlorite‐induced SSc to investigate the systemic effects of MSCs on the main features of the diffuse form of the disease: skin and lung fibrosis, autoimmunity, and oxidative status.
Biology,Medicine,Environmental Science
What problem does this paper attempt to address?